导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 11.78% | 272/1050 |
| 近一周 | -2.67% | 691/1104 |
| 近一月 | -8.89% | 981/1102 |
| 近一季 | -10.54% | 686/1092 |
| 近半年 | 12.90% | 219/1070 |
| 近一年 | 5.40% | 459/1018 |
| 近两年 | 45.45% | 534/926 |
| 近三年 | 14.05% | 557/834 |
| 成立以来 | 74.52% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.32% 877/1070 |
51.63% 224/1101 |
- - |
- - |
| 2025 | 11.50% 813/1065 |
3.78% 494/1014 |
-4.00% 932/1038 |
20.77% 585/1050 |
-7.34% 814/1065 |
| 2024 | -4.60% 694/1011 |
-1.98% 420/960 |
-6.93% 742/983 |
9.39% 671/991 |
-4.40% 623/1011 |
| 2023 | -16.98% 599/952 |
3.11% 439/880 |
-12.54% 820/895 |
-4.23% 251/915 |
-3.88% 395/952 |
| 2022 | -14.66% 164/867 |
-20.99% 577/773 |
18.45% 38/806 |
-13.45% 490/845 |
5.36% 188/867 |
| 2021 | -2.17% 381/740 |
-5.52% 361/580 |
12.22% 304/659 |
-12.94% 575/704 |
5.98% 183/740 |
| 2020 | 88.56% 63/554 |
-1.66% 205/419 |
28.87% 140/466 |
25.89% 15/517 |
18.19% 149/554 |
| 2019 | 58.10% 89/410 |
35.29% 135/1146 |
2.58% 136/1228 |
3.41% 235/390 |
10.17% 156/410 |
| 2018 | -29.96% 212/349 |
- - |
-3.39% 149/990 |
-12.70% 892/1000 |
-12.92% 722/1080 |
| 2017 | 34.71% 23/285 |
- - |
- - |
- - |
- - |
| 2016 | -15.76% 96/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 银华中国梦30股票 VS. 东吴新产业精选股票A(580008) |